07th week of 2021 patent applcation highlights part 22 |
Patent application number | Title | Published |
20210047379 | PROTEASE-RESISTANT NEUROTROPHIC PEPTIDE FOR THE THERAPEUTIC TREATMENT OF NEURODEGENERATIVE AND/OR SKIN DISEASES | 2021-02-18 |
20210047380 | A NEUROTROPHIC PEPTIDE FOR THE THERAPEUTIC TREATMENT OF NEURODEGENERATIVE AND/OR INFLAMMATORY DISEASES | 2021-02-18 |
20210047381 | Production of Glycoproteins Using Manganese | 2021-02-18 |
20210047382 | MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES | 2021-02-18 |
20210047383 | MHC Multimers in Borrelia Diagnostics and Disease | 2021-02-18 |
20210047384 | SYNTAC POLYPEPTIDES AND USES THEREOF | 2021-02-18 |
20210047385 | NERVE CELL CULTURE MATERIAL AND THERAPEUTIC AGENT FOR NERVE DAMAGE | 2021-02-18 |
20210047386 | CUSTOMIZED CLASS SWITCH OF IMMUNOGLOBULIN GENES IN LYMPHOMA AND HYBRIDOMA BY CRISPR/CAS9 TECHNOLOGY | 2021-02-18 |
20210047387 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | 2021-02-18 |
20210047388 | NUCLEIC ACID ANTIBODY CONSTRUCTS FOR USE AGAINST EBOLA VIRUS | 2021-02-18 |
20210047389 | ANTI-INFLUENZA NEURAMINIDASE MONOCLONAL ANTIBODIES AND USES THEREOF | 2021-02-18 |
20210047390 | NUCLEIC ACID ANTIBODY CONSTRUCTS FOR USE AGAINST RESPIRATORY SYNCYTIAL VIRUS | 2021-02-18 |
20210047391 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | 2021-02-18 |
20210047392 | METHOD FOR THE PRODUCTION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | 2021-02-18 |
20210047393 | BINDING MOLECULES THAT SPECIFICALLY BIND TO TAU | 2021-02-18 |
20210047394 | BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES | 2021-02-18 |
20210047395 | METHOD FOR IMPROVING VEGF-RECEPTOR BLOCKING SELECTIVITY OF AN ANTI-VEGF ANTIBODY | 2021-02-18 |
20210047396 | LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOF | 2021-02-18 |
20210047397 | METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE | 2021-02-18 |
20210047398 | ASPROSIN, A FAST-INDUCED GLUCOGENIC PROTEIN HORMONE | 2021-02-18 |
20210047399 | ANTI-DLL3 ANTIBODIES AND USES THEREOF | 2021-02-18 |
20210047400 | A PROGNOSTIC BIOMARKER IN CANCER | 2021-02-18 |
20210047401 | Anti-CD38 Antibodies for Treatment of Acute Myeloid Leukemia | 2021-02-18 |
20210047402 | MULTISPECIFIC HEAVY CHAIN ANTIBODIES BINDING TO CD22 AND CD3 | 2021-02-18 |
20210047403 | IMMUNORECEPTOR MODULATION FOR TREATING CANCER AND VIRAL INFECTIONS | 2021-02-18 |
20210047404 | CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER | 2021-02-18 |
20210047405 | CAR T CELL THERAPIES WITH ENHANCED EFFICACY | 2021-02-18 |
20210047406 | BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANTIBODIES, AND METHODS OF USING THE SAME | 2021-02-18 |
20210047407 | LOW PH PHARMACEUTICAL ANTIBODY FORMULATION | 2021-02-18 |
20210047408 | METHODS FOR TREATING CANCER WITH ANTI-PD-1 ANTIBODIES | 2021-02-18 |
20210047409 | METHODS FOR TREATING CANCER WITH ANTI PD-1 ANTIBODIES AND ANTI CTLA4 ANTIBODIES | 2021-02-18 |
20210047410 | METHODS OF SELECTING AND DESIGNING SAFER AND MORE EFFECTIVE ANTI-CTLA-4 ANTIBODIES FOR CANCER THERAPY | 2021-02-18 |
20210047411 | METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28 | 2021-02-18 |
20210047412 | CANINE ANTIBODY THERAPEUTIC FOR TREATING CANCER | 2021-02-18 |
20210047413 | METHODS AND COMPOSITIONS FOR TREATING, INHIBITING, AND/OR PREVENTING HETEROTOPIC OSSIFICATION | 2021-02-18 |
20210047414 | COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE | 2021-02-18 |
20210047415 | PD1 BINDING AGENTS | 2021-02-18 |
20210047416 | TREATMENT OF OVARIAN CANCER WITH ANTI-CD47 AND ANTI-PD-L1 | 2021-02-18 |
20210047417 | MICA/B ANTIBODIES AND METHODS OF USE | 2021-02-18 |
20210047418 | ANTIBODY AGAINST ALPHA-11 INTEGRIN AND ITS USE | 2021-02-18 |
20210047419 | TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY RECEPTOR BINDING MOLECULES AND USES THEREOF | 2021-02-18 |
20210047420 | ANTI-CD25 FOR TUMOUR SPECIFIC CELL DEPLETION | 2021-02-18 |
20210047421 | Pharmaceutical Composition for Cancer Treatment | 2021-02-18 |
20210047422 | BI-SPECIFIC ANTI-CGRP RECEPTOR/PAC1 RECEPTOR ANTIGEN BINDING PROTEINS AND USES THEREOF | 2021-02-18 |
20210047423 | THERAPEUTIC IMMUNE CELLS WITH IMPROVED FUNCTION AND METHODS FOR MAKING THE SAME | 2021-02-18 |
20210047424 | IMMUNOMODULATORY ANTIBODIES AND METHODS OF USE THEREOF | 2021-02-18 |
20210047425 | METHODS AND COMPOSITIONS FOR PROMOTING AND POTENTIATING T-CELL MEDIATED IMMUNE RESPONSES THROUGH ADCC TARGETING OF CD39 EXPRESSING CELLS | 2021-02-18 |
20210047426 | Bi-Specific Monovalent Diabodies That are Capable of Binding CD123 and CD3, and Uses Thereof | 2021-02-18 |
20210047427 | SUBCUTANEOUS DOSING OF ANTI-CD38 ANTIBODIES | 2021-02-18 |
20210047428 | METHOD FOR GENERATING ANTIBODIES WITH IMPROVED SPECIFICITY AND/OR AFFINITY | 2021-02-18 |
20210047429 | TREATMENT OF METASTIC BREAST CANCER | 2021-02-18 |
20210047430 | NOVEL AFFINITY CHROMATOGRAPHY MEDIA FOR REMOVAL OF ANTI-A AND/OR ANTI-B ANTIBODIES | 2021-02-18 |
20210047431 | ANTI-PLA2-GIB ANTIBODIES AND THE USES THEREOF | 2021-02-18 |
20210047432 | THERAPEUTIC ANTI-SPLA2-GIB ANTIBODIES AND THE USES THEREOF | 2021-02-18 |
20210047433 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | 2021-02-18 |
20210047434 | METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS | 2021-02-18 |
20210047435 | MATERIALS AND METHODS FOR IMPROVED SINGLE CHAIN VARIABLE FRAGMENTS | 2021-02-18 |
20210047436 | ANTI- POLYSIALIC ACID ANTIBODIES AND USES THEREOF | 2021-02-18 |
20210047437 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | 2021-02-18 |
20210047438 | Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof | 2021-02-18 |
20210047439 | DLL3 BINDING PROTEINS AND METHODS OF USE | 2021-02-18 |
20210047440 | AMPHIPHILIC POLYSACCHARIDES, POLYSACCHARIDE-BASED HYDROGELS, AND METHODS OF MANUFACTURE | 2021-02-18 |
20210047441 | ANTHOCYANIDIN COMPLEX | 2021-02-18 |
20210047442 | CONTROLLING A POLYMERIZATION REACTION | 2021-02-18 |
20210047443 | Polyethylene and Chlorinated Polyethylene Thereof | 2021-02-18 |
20210047444 | METHODS OF PREPARING A CATALYST UTILIZING HYDRATED REAGENTS | 2021-02-18 |
20210047445 | PRODUCING A POLYETHYLENE POLYMER | 2021-02-18 |
20210047446 | MODIFIED RESIN FOR MOLDED ARTICLE AND GOLF BALL | 2021-02-18 |
20210047447 | MOLDED PRODUCT COMPRISING POLARIZED OLEFIN-BASED POLYMER AND PROPERTY THEREOF | 2021-02-18 |
20210047448 | VINYLIDENE FLUORIDE POLYMER, BINDER COMPOSITION, ELECTRODE MIXTURE, ELECTRODE, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY, AND METHOD FOR PRODUCING ELECTRODE MIXTURE | 2021-02-18 |
20210047449 | COPOLYMER AND COLORED RESIN COMPOSITION | 2021-02-18 |
20210047450 | METHACRYLAMIDE ADHESIVE SYSTEMS | 2021-02-18 |
20210047451 | COPOLYMER AND METHOD FOR PRODUCING SAME | 2021-02-18 |
20210047452 | BORONIC ACID DERIVATIVES FOR DIOL-SENSING HYDROGELS | 2021-02-18 |
20210047453 | MULTI-STAGE LATEX PARTICLES WITH PEG IN OUTER STAGE | 2021-02-18 |
20210047454 | Producing Blocks of Block Copolymer In a Separator Downstream of a Reactor | 2021-02-18 |
20210047455 | Block Copolymer Containing Photo-Sensitive Moiety | 2021-02-18 |
20210047456 | Compositions for forming polymer brushes | 2021-02-18 |
20210047457 | COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD | 2021-02-18 |
20210047458 | EPOXY RESIN MODIFIED WITH POLYURETHANE IN LOW CONCENTRATION, PRODUCTION METHOD THEREFOR, EPOXY RESIN COMPOSITION, AND CURED OBJECT | 2021-02-18 |
20210047459 | Epoxy Resin Material, Preparation Method Therefor And Application Thereof | 2021-02-18 |
20210047460 | FAST-CURE RESIN FORMULATIONS WITH CONSISTENT HANDLING CHARACTERISTICS | 2021-02-18 |
20210047461 | PHENALKAMINE EPOXY CURING AGENTS AND EPOXY RESIN COMPOSITIONS CONTAINING THE SAME | 2021-02-18 |
20210047462 | METHOD FOR SYNTHESIZING POLYOLEFIN MATERIAL WITH CONTROLLED DEGREE OF BRANCHING | 2021-02-18 |
20210047463 | POLYCARBONATE RESIN AND METHOD FOR MANUFACTURING SAME | 2021-02-18 |
20210047464 | POLYMER COMPOSITION | 2021-02-18 |
20210047465 | HETEROBIFUNCTIONAL COMPOUND HAVING MONODISPERSED POLYETHYLENE GLYCOL IN MAIN CHAIN AND SIDE CHAIN | 2021-02-18 |
20210047466 | BIO-BASED POLYARYLENE ETHER RESIN CONTAINING FURAN RING STRUCTURE AND PREPARATION METHOD THEREFOR | 2021-02-18 |
20210047467 | AMPHIPHILIC BLOCK COPOLYMER, PREPARATION METHOD THEREOF AND NANOMICELLE DRUG-LOADING SYSTEM | 2021-02-18 |
20210047468 | POLYAMIDE PARTICLES AND METHOD FOR PRODUCING POLYAMIDE PARTICLES | 2021-02-18 |
20210047469 | LOW FRICTION RESIN COMPOSITES | 2021-02-18 |
20210047470 | ALKALI-SOLUBLE RESIN, PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE SHEET, CURED FILM, INTERLAYER INSULATING FILM OR SEMICONDUCTOR PROTECTIVE FILM, PRODUCTION METHOD FOR RELIEF PATTERN OF CURED FILM, AND ELECTRONIC COMPONENT OR SEMICONDUCTOR DEVICE | 2021-02-18 |
20210047471 | High Molecular Weight Polyphenylene Sulfide Resin, Preparation Method and Use Thereof | 2021-02-18 |
20210047472 | DYNAMIC COVALENT POLYMERIZATIONS WITH ELEMENTAL SULFUR AND SULFUR PREPOLYMERS | 2021-02-18 |
20210047473 | SILICONE RUBBER-SILICONE MODIFIED POLYIMIDE RESIN LAMINATED BODY | 2021-02-18 |
20210047474 | CROSSLINKED POLYETHER-SILOXANE BLOCK COPOLYMERS AND THEIR USE FOR PRODUCING POLYURETHANE FOAMS | 2021-02-18 |
20210047475 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | 2021-02-18 |
20210047476 | Polymeric BODIPY Dyes and Methods for Using the Same | 2021-02-18 |
20210047477 | PHOTODYNAMIC CATIONIC PORPHYRIN COMPOSITES | 2021-02-18 |
20210047478 | MOLECULAR DNA STRAND-DISPLACEMENT CONTROLLERS FOR DIRECTING MATERIAL EXPANSION | 2021-02-18 |